Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18633352 | Treatment and prevention of neuropathology associated with neurodegenerative diseases | April 2024 | March 2025 | Allow | 11 | 0 | 0 | Yes | No |
| 18405102 | PREGABALIN ARTIFICIAL HAPTEN, ARTIFICIAL ANTIGEN AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | January 2024 | March 2025 | Allow | 14 | 0 | 0 | Yes | No |
| 18399556 | RECOMBINANT ALGAE HAVING HIGH LIPID PRODUCTIVITY | December 2023 | April 2025 | Allow | 16 | 1 | 0 | Yes | No |
| 18493878 | SENSORS FOR DETECTING AND IMAGING OF CANCER METASTASIS | October 2023 | June 2025 | Abandon | 20 | 0 | 1 | No | No |
| 18555515 | A composition comprising Pediococcus Pentosaceus for use in treatment and/or prevention of food and/or alcohol poisoning | October 2023 | January 2025 | Allow | 15 | 1 | 1 | Yes | No |
| 18241774 | LARGE SCALE PEI-MEDIATED PLASMID TRANSFECTION | September 2023 | January 2026 | Abandon | 28 | 2 | 1 | No | No |
| 18358682 | METHODS AND COMPOSITIONS FOR TREATING SOIL AND PLANTS | July 2023 | September 2024 | Allow | 14 | 1 | 1 | Yes | No |
| 18324954 | METHOD FOR ASSESSING MICROBIAL DRUG RESISTANCE MULTI-LEVEL RISKS OF ANTIBIOTIC RESIDUES IN WATER ENVIRONMENT | May 2023 | January 2024 | Allow | 8 | 1 | 0 | No | No |
| 18035149 | MODIFIED URICASE AND USES THEREOF | May 2023 | March 2026 | Allow | 34 | 2 | 1 | No | No |
| 18044373 | NBP-14 FOR TREATING ALZHEIMER'S ASSOCIATED WITH DOWN'S SYNDROME | March 2023 | February 2026 | Abandon | 35 | 0 | 1 | No | No |
| 18110325 | RARE EARTH METAL EXTRACTING BACTERIAL CONSORTIA | February 2023 | August 2025 | Abandon | 30 | 2 | 1 | No | No |
| 18169487 | MICROORGANISM PRODUCING EICOSAPENTAENOIC ACID AND METHOD FOR PRODUCING EICOSAPENTAENOIC ACID | February 2023 | March 2024 | Allow | 13 | 3 | 0 | Yes | No |
| 17981867 | SECONDARY METABOLITE SCREENING SYSTEM | November 2022 | August 2024 | Abandon | 22 | 1 | 1 | No | No |
| 17923517 | METHOD FOR PREPARING A FATTY AMIDOALKYLDIALKYLAMINE | November 2022 | November 2025 | Allow | 37 | 1 | 1 | No | No |
| 17919424 | Engineered Probiotics for Treatment and Immunity against Viruses | October 2022 | December 2025 | Allow | 38 | 1 | 1 | Yes | No |
| 17962796 | STABLE DRY POWDERS AND EMULSIONS CONTAINING PROBIOTICS | October 2022 | October 2024 | Allow | 24 | 1 | 1 | Yes | No |
| 17957224 | COMPOSITION SUITABLE FOR PROTECTING MICROORGANISMS | September 2022 | February 2024 | Allow | 16 | 2 | 0 | Yes | No |
| 17801854 | RECOMBINANT BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED WITH URIC ACID AND METHODS OF USE THEREOF | August 2022 | December 2025 | Abandon | 40 | 0 | 1 | No | No |
| 17828332 | RECOMBINANT MICROORGANISM HAVING ENHANCED ABILITY TO REMOVE NITRIC OXIDE AND USE THEREOF | May 2022 | October 2025 | Abandon | 41 | 2 | 1 | No | No |
| 17762324 | ASSAY OF ARYLSULFATASE A ENZYMATIC ACTIVITY IN DRIED BLOOD SPOTS BY MASS SPECTROMETRY AND FLUOROMETRY | March 2022 | March 2025 | Abandon | 35 | 3 | 1 | No | No |
| 17675009 | METHOD FOR CULTURING HAEMATOCOCCUS PLUVIALIS CONTAINING LARGE AMOUNT OF ASTAXANTHIN | February 2022 | December 2024 | Abandon | 34 | 3 | 0 | No | No |
| 17636322 | PRODUCTION OF CANNABINOIDS | February 2022 | July 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17667058 | CONTROLLING MULTIPLE HETEROGENOUS MAGNETIC BACTERIA AT A SOLID-LIQUID INTERFACE USING UNIFORM MAGNETIC FIELDS | February 2022 | September 2025 | Abandon | 43 | 4 | 1 | Yes | No |
| 17630657 | METHOD FOR PRODUCING MONOPHOSPHORYL LIPID A | January 2022 | September 2024 | Allow | 31 | 2 | 1 | Yes | No |
| 17626801 | L-2-HYDROXYGLUTARATE BIOSENSOR BASED ON SPECIFIC TRANSCRIPTIONAL REGULATOR AND APPLICATION THEREOF | January 2022 | July 2025 | Allow | 42 | 1 | 1 | No | No |
| 17625713 | Systems and Methods for Determining Antimicrobial Resistance of a Sample Using Surface Topography Determined from Optical Imaging Data | January 2022 | February 2026 | Abandon | 49 | 2 | 1 | No | No |
| 17623503 | Recombinant Heme Oxygenase-1 (HO-1) for the Treatment of Sickle Cell Disease | December 2021 | January 2026 | Allow | 48 | 3 | 1 | No | No |
| 17622070 | NOVEL DIAGNOSTIC MARKER FOR PANCREATIC CANCER | December 2021 | August 2025 | Allow | 44 | 2 | 0 | Yes | No |
| 17620927 | METHODS AND COMPOSITIONS RELATED TO PRINTED CELLULAR NICHES FOR PRESERVING AND CONTROLLING SYNTHETIC MICROBIAL CONSORTIA | December 2021 | August 2025 | Abandon | 44 | 3 | 1 | No | No |
| 17555262 | NOVEL GLUCOSE OXIDASE COMPOSITIONS | December 2021 | January 2025 | Abandon | 37 | 0 | 1 | No | No |
| 17618725 | PROCESSED MICROBIAL EXTRACELLULAR VESICLES | December 2021 | January 2025 | Abandon | 37 | 0 | 1 | No | No |
| 17612970 | RIBULOSE-PHOSPHATE 3-EPIMERASE MOTIF HAVING LOW SIDE REACTIVITY AND ENZYME INCLUDING THE SAME | November 2021 | March 2025 | Allow | 40 | 1 | 1 | Yes | No |
| 17455173 | Treatment and prevention of neuropathology associated with neurodegenerative diseases | November 2021 | January 2024 | Allow | 26 | 2 | 0 | No | No |
| 17605671 | MICROORGANISM FOR PRODUCING L-AMINO ACID HAVING INCREASED CYTOCHROME C ACTIVITY, AND L-AMINO ACID PRODUCTION METHOD USING SAME | October 2021 | May 2025 | Allow | 43 | 2 | 1 | No | No |
| 17485682 | Feruloyl Esterase and Application thereof | September 2021 | January 2025 | Allow | 40 | 2 | 1 | No | No |
| 17482391 | PROCESS AND SYSTEM FOR GENERATING HYDROGEN | September 2021 | May 2025 | Allow | 43 | 2 | 1 | Yes | No |
| 17439600 | Co-Culture of Myxobacteria and Bacillus for Enhanced Metabolite Production | September 2021 | January 2024 | Allow | 28 | 1 | 1 | Yes | No |
| 17447266 | GAS FERMENTATION FOR THE PRODUCTION OF PROTEIN-BASED BIOPLASTICS | September 2021 | January 2025 | Abandon | 41 | 1 | 1 | No | No |
| 17398841 | PREGABALIN ARTIFICIAL HAPTEN, ARTIFICIAL ANTIGEN AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | August 2021 | October 2023 | Allow | 27 | 1 | 1 | Yes | No |
| 17427834 | OPTIMIZED METHOD FOR INDUSTRIAL EXPLOITATION OF UNICELLULAR RED ALGAE | August 2021 | December 2024 | Abandon | 41 | 2 | 1 | No | No |
| 17422373 | MICROBIOME ENGINEERING THROUGH ENGINEERED MOBILE GENETIC ELEMENTS | July 2021 | May 2025 | Abandon | 46 | 1 | 1 | No | No |
| 17367224 | BIOLOGICAL INDICATOR FOR DETERMINING THE EFFICACY OF AN OXIDATIVE STERILIZATION PROCESS AND METHODS OF USE | July 2021 | August 2025 | Allow | 49 | 5 | 1 | Yes | No |
| 17418759 | ONCOLYTIC VIRUS EXPRESSING INTERFERON AND APPLICATION THEREFOR | June 2021 | January 2025 | Allow | 43 | 1 | 1 | Yes | No |
| 17413672 | Method For Increasing The Production Of Biomass and Lipids in Chlorella Vulgaris | June 2021 | January 2024 | Abandon | 31 | 1 | 0 | No | No |
| 17311426 | MICROALGAL STRAIN AND ITS USE FOR THE PRODUCTION OF LIPIDS | June 2021 | September 2023 | Allow | 27 | 1 | 0 | No | No |
| 17293189 | METHOD FOR PRODUCING SECRETED BETA-GALACTOSIDASE | May 2021 | September 2025 | Allow | 53 | 2 | 1 | Yes | No |
| 17306251 | ADVANCED ANAEROBIC DIGESTION TO CARBOXYLIC ACIDS | May 2021 | December 2024 | Allow | 43 | 4 | 0 | Yes | No |
| 17286306 | ENZYME ADDITION TO OMEGA 3 FERMENTATION BROTH FOR THE REDUCTION OF OLIGOSACCHARIDES THROUGH STERILIZED DEXTROSE SOLUTION | April 2021 | November 2023 | Allow | 31 | 0 | 1 | Yes | No |
| 17279686 | ALKALINE PHOSPHATASE COMPOSITION, METHOD OF PRODUCING DEPHOSPHORYLATED NUCLEIC ACID AND METHOD OF PRODUCING LABELED NUCLEIC ACID | March 2021 | February 2024 | Allow | 35 | 0 | 0 | No | No |
| 17203599 | METHOD OF ISOLATING NUCLEIC ACIDS FOR LONG SEQUENCING READS | March 2021 | November 2025 | Abandon | 56 | 3 | 1 | No | No |
| 17273678 | METHOD FOR ENRICHING A BIOMASS WITH PROTEINS | March 2021 | January 2026 | Allow | 58 | 6 | 0 | Yes | No |
| 17272862 | MICROORGANISM AND METHOD FOR PRODUCING TRIACYLGLYCEROL | March 2021 | June 2023 | Allow | 28 | 3 | 0 | Yes | No |
| 17267347 | MICROORGANISMS WITH IMPROVED 1,3-PROPANEDIOL AND BUTYRIC ACID PRODUCTION | February 2021 | July 2023 | Allow | 29 | 1 | 1 | Yes | No |
| 17266984 | MICROORGANISM PRODUCING EICOSAPENTAENOIC ACID AND METHOD FOR PRODUCING EICOSAPENTAENOIC ACID | February 2021 | November 2022 | Allow | 21 | 1 | 0 | Yes | No |
| 17161889 | Nanoparticle-Based Lipase Biosensor Utilizing a Custom-Synthesized Peptidyl-Ester Substrate | January 2021 | June 2023 | Allow | 28 | 1 | 0 | Yes | No |
| 17153106 | CROP PROTECTION IN ALGAE BY EXOGENOUS TERPENE EXPRESSION | January 2021 | October 2023 | Allow | 33 | 2 | 1 | No | No |
| 17260293 | ENCAPSULATED MICROORGANISMS AND METHODS OF USING SAME | January 2021 | March 2023 | Allow | 26 | 2 | 0 | Yes | No |
| 17258832 | D-XYLOSE DEHYDROGENASE FROM CORYNEFORM BACTERIA AND PROCESS FOR PREPARING D-XYLONATE | January 2021 | January 2025 | Allow | 49 | 3 | 1 | Yes | No |
| 17137464 | METHOD FOR PREPARING VANILLIN BY FERMENTATION WITH EUGENOL AS SUBSTRATE | December 2020 | May 2022 | Allow | 16 | 1 | 0 | No | No |
| 17137887 | Polypeptides with Lipase Activity and Uses Thereof | December 2020 | May 2023 | Allow | 29 | 2 | 1 | Yes | No |
| 17124348 | RECOMBINANT ALGAE HAVING HIGH LIPID PRODUCTIVITY | December 2020 | August 2023 | Allow | 32 | 2 | 0 | Yes | No |
| 15734484 | MICROBIAL CONSORTIA PRODUCING DIPICOLINIC ACID AND METHODS FOR SELECTING MICROBES FOR CO-FORMULATION WITH CARRIERS | December 2020 | May 2025 | Allow | 53 | 2 | 1 | Yes | No |
| 17055576 | METHOD FOR OBTAINING FAT-SOLUBLE AND WATER-SOLUBLE COMPOUNDS FROM MICROALGAE BY MODULATING THE POLARITY OF VEGETABLE OR ANIMAL OILS | November 2020 | January 2024 | Abandon | 38 | 2 | 1 | No | No |
| 17051248 | COMPOSITIONS AND METHODS OF PHOSPHOLIPASE A2 RECEPTOR CHIMERIC AUTOANTIBODY RECEPTOR T CELLS | October 2020 | July 2024 | Abandon | 44 | 0 | 1 | No | No |
| 17082594 | Bacteroides ovatus for Relieving Endotoxin Infection and Application thereof | October 2020 | April 2022 | Allow | 18 | 1 | 0 | Yes | No |
| 17049855 | Increasing activity of 2'fucosyllactose transporters endogenous to microbial cells | October 2020 | April 2024 | Allow | 42 | 5 | 1 | Yes | No |
| 17071947 | LACTIC ACID BACTERIAL COMPOSITION FOR THE TREATMENT OF BACTERIAL VAGINAL INFECTIONS BY GARDNERELLA VAGINALIS AND, IF PRESENT, OF CONCURRENT FUNGAL INFECTIONS | October 2020 | February 2025 | Allow | 52 | 5 | 0 | Yes | No |
| 17045141 | TERPENE GLYCOSIDE DERIVATIVES AND USES THEREOF | October 2020 | April 2025 | Abandon | 54 | 2 | 1 | No | No |
| 17036736 | BACTERIA IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY TEST | September 2020 | June 2022 | Abandon | 20 | 0 | 1 | No | No |
| 17040127 | BIOLOGICAL SUBSTANCE DETECTION SENSOR | September 2020 | April 2024 | Abandon | 43 | 0 | 1 | No | No |
| 17020596 | DYNAMICALLY-ADAPTIVE LIVE THERAPEUTIC AGENTS AND METHODS OF USE THEREOF | September 2020 | January 2023 | Allow | 28 | 0 | 1 | Yes | No |
| 16975321 | MODIFIED PlySs2 LYSINS AND USES THEREOF | August 2020 | July 2024 | Abandon | 47 | 1 | 1 | No | No |
| 16966322 | IN-VITRO MODEL OF THE HUMAN GUT MICROBIOME AND USES THEREOF IN THE ANALYSIS OF THE IMPACT OF XENOBIOTICS | July 2020 | June 2025 | Allow | 59 | 6 | 1 | Yes | No |
| 16965184 | THERAPEUTIC AGENT FOR FRONTOTEMPORAL LOBAR DEGENERATION, METHOD FOR SCREENING THERAPEUTIC AGENT FOR FRONTOTEMPORAL LOBAR DEGENERATION AND METHOD FOR TREATING FRONTOTEMPORAL LOBAR DEGENERATION | July 2020 | July 2024 | Abandon | 48 | 1 | 0 | No | No |
| 16938052 | POST-SPORULATION MODIFICATION OF SPORES AND BIOLOGICAL INDICATOR | July 2020 | October 2022 | Allow | 27 | 1 | 1 | No | No |
| 16937055 | METHODS FOR MITIGATING THE INHIBITORY EFFECTS OF LIGNIN AND SOLUBLE PHENOLICS FOR ENZYMATIC CONVERSION OF CELLULOSE | July 2020 | January 2022 | Allow | 18 | 0 | 0 | Yes | No |
| 16903068 | WHOLE STILLAGE SEPARATION | June 2020 | October 2021 | Allow | 16 | 0 | 0 | Yes | No |
| 16772588 | COMPOSITIONS AND METHODS TO DETECT MICROORGNAISMS | June 2020 | May 2024 | Abandon | 47 | 5 | 1 | No | No |
| 16897798 | COMPOSITION SUITABLE FOR PROTECTING MICROORGANISMS | June 2020 | June 2022 | Allow | 24 | 1 | 1 | Yes | No |
| 16758950 | CULTURING METHOD FOR GENUS RHIZOBIUM BACTERIA | April 2020 | October 2023 | Allow | 42 | 3 | 0 | Yes | No |
| 16759077 | A Strain Of Bactericidal Nitrogen-Fixing Pseudomonas Protegens, A Fermentation Method And An Application Thereof | April 2020 | November 2022 | Abandon | 31 | 3 | 1 | No | No |
| 16837148 | METHOD OF THREE-DIMENSIONAL MICROORGANISMS BIOFILMS FABRICATION | April 2020 | December 2022 | Abandon | 32 | 1 | 0 | No | No |
| 16651760 | METHODS AND DEVICES | March 2020 | October 2022 | Abandon | 30 | 0 | 1 | No | No |
| 16648872 | PRODUCTION OF RETINYL ESTERS | March 2020 | October 2023 | Allow | 43 | 2 | 2 | Yes | No |
| 16648879 | PRODUCTION OF RETINYL ESTERS | March 2020 | March 2024 | Allow | 48 | 2 | 2 | Yes | Yes |
| 16823330 | Medium Material for Removing Phenol Contamination from Groundwater, Method of Producing the Same, and Use of the Same | March 2020 | November 2022 | Allow | 32 | 1 | 0 | Yes | No |
| 16824500 | IMMUNOSTIMULATORY BACTERIA ENGINEERED TO COLONIZE TUMORS, TUMOR-RESIDENT IMMUNE CELLS, AND THE TUMOR MICROENVIRONMENT | March 2020 | February 2024 | Allow | 47 | 3 | 1 | No | No |
| 16646936 | MEANS AND METHODS TO MODULATE PROBIOTIC POTENCY OF THE YEAST SACCHAROMYCES BOULARDII | March 2020 | March 2024 | Allow | 48 | 3 | 0 | Yes | No |
| 16804562 | COMPOSITION AND METHOD FOR CONTROLLING BACTERIA IN FORMATIONS | February 2020 | May 2024 | Allow | 51 | 5 | 0 | Yes | No |
| 16787149 | PROCESS AND METHOD FOR STILLAGE FERMENTATION | February 2020 | October 2022 | Abandon | 32 | 2 | 0 | No | No |
| 16635474 | NOVEL PSICOSE-6-PHOSPHATE PHOSPHATASE, COMPOSITION FOR PRODUCING PSICOSE INCLUDING SAID ENZYME, METHOD FOR PRODUCING PSICOSE USING SAID ENZYME | January 2020 | September 2024 | Allow | 55 | 4 | 1 | Yes | No |
| 16745748 | SENSORS FOR DETECTING AND IMAGING OF CANCER METASTASIS | January 2020 | July 2023 | Allow | 42 | 3 | 1 | No | No |
| 16741899 | METHOD OF SAMPLE PREPARATION ON A SPECTROMETRIC SAMPLE SUPPORT | January 2020 | July 2023 | Allow | 42 | 3 | 0 | No | No |
| 16626008 | IMPROVED REVERSE TRANSCRIPTASE AND METHODS OF USE | December 2019 | January 2023 | Allow | 36 | 1 | 1 | Yes | No |
| 16624569 | ASSAY FOR SCREENING MODULATORS OF HOLOPHOSPHATASE ACTIVITY | December 2019 | January 2023 | Abandon | 37 | 0 | 1 | No | No |
| 16700557 | GENETICALLY MODIFIED ALGA, SEQUENCES AND METHODS THEREOF | December 2019 | November 2022 | Allow | 35 | 1 | 1 | Yes | No |
| 16615705 | PHOSPHATIDYLINOSITOL QUANTIFICATION METHOD AND QUANTIFICATION KIT | November 2019 | June 2022 | Allow | 31 | 2 | 0 | No | No |
| 16612075 | PLANT GROWTH-PROMOTING MICROBES, COMPOSITIONS, AND USES | November 2019 | May 2024 | Abandon | 55 | 3 | 1 | No | No |
| 16667045 | METHODS AND COMPOSITIONS FOR TREATING SOIL AND PLANTS | October 2019 | April 2023 | Allow | 42 | 2 | 0 | No | No |
| 16665210 | DEMONSTRABLE EFFICACY ACROSS OR WITHIN PATIENT POPULATIONS | October 2019 | April 2022 | Abandon | 30 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner KANE, TREVOR LOGAN.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner KANE, TREVOR LOGAN works in Art Unit 1657 and has examined 85 patent applications in our dataset. With an allowance rate of 65.9%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 42 months.
Examiner KANE, TREVOR LOGAN's allowance rate of 65.9% places them in the 27% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by KANE, TREVOR LOGAN receive 2.04 office actions before reaching final disposition. This places the examiner in the 53% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by KANE, TREVOR LOGAN is 42 months. This places the examiner in the 18% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +62.7% benefit to allowance rate for applications examined by KANE, TREVOR LOGAN. This interview benefit is in the 97% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 28.0% of applications are subsequently allowed. This success rate is in the 50% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 26.1% of cases where such amendments are filed. This entry rate is in the 36% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 1% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 47% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 50.0% are granted (fully or in part). This grant rate is in the 46% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.